Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Lidocaine vs Fentanyl for Postoperative Pain in Gynecologic Surgery
NCT07213687Phase 4Completed
- Sponsor
- Dilla University
- Start
- Jun 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ketamine and Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by Dilla University. Primary endpoint: Postoperative Pain Severity (Numerical Rating Scale) at 24 hours. Started Jun 2023; status: completed.
02
Drugs
ketamineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07213687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07213687.